Kusajili – Clinical trials directory

Result of your search per sponsor: Janssen Pharmaceuticals, Inc

Woman and Man Max 99 years
Janssen Pharmaceuticals, Inc Update Il y a 4 ans

A study comparing the safety and effects of a new compound, ACI-35 with placebo in patients with mild to moderate Alzheimer's disease Background and study aims Alzheimer’s disease (AD) is the most common cause of dementia, creating problems with memory, thinking and behaviour (cognitive function). It is a growing problem worldwide, ...

Country None
organs None
Specialty None

Closed trial

More information